Evercore ISI Starts Forte Biosciences Inc. (FBRX) at Outperform Nov 25, 2025 06:49AM
Forte Biosciences (FBRX) Misses Q3 EPS by 99c Nov 14, 2025 04:11PM
Guggenheim Starts Forte Biosciences Inc. (FBRX) at Buy, PT $75 Aug 18, 2025 06:10AM
Forte Biosciences Inc. (FBRX) PT Lowered to $54 at Brookline Capital Markets Aug 15, 2025 03:01PM
Forte Biosciences (FBRX) Misses Q2 EPS by 96c Aug 14, 2025 05:42PM


Jun 24, 2025 04:01PM Forte Biosciences (FBRX) Announces Proposed Share Offering
Jun 23, 2025 07:19AM Forte Biosciences (FBRX) Announces Positive Data in FB102 Celiac Disease Phase 1B Study
May 15, 2025 06:53PM Forte Biosciences (FBRX) Misses Q1 EPS by 137c
Mar 28, 2025 04:46PM Forte Biosciences (FBRX) Files $300M Mixed Shelf
Jan 21, 2025 05:33AM TD Cowen Starts Forte Biosciences Inc. (FBRX) at Buy
Nov 20, 2024 09:19AM Forte Biosciences (FBRX) Announces Oversubscribed $53 Million Private Placement From Leading Healthcare Institutional Investors to Advance FB102 Across Autoimmune Indications
Nov 15, 2024 06:18AM Forte Biosciences (FBRX) Misses Q3 EPS by 433c